MoneyWorks4Me

Mangalam Drugs & Organics informs about outcome of board meeting

16 Nov 2015 Evaluate

Mangalam Drugs & Organics has informed that the Board of Directors of the Company at its meeting held on November 16, 2015, has transacted the approval of allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share warrants of Rs 10 each at a premium of Rs 55 per share out of the total 26,50,000 Warrants allotted to promoter group on preferential basis, upon the receipt of balance consideration amount on it.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..